BREATHOMIX
LIVE

Serial Number

79305557

Owner

Breathomix Intellectual Property B.V.

Filing Date

Nov 6, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BREATHOMIX Trademark

Serial Number: 79305557 • Registration: 6688571

BREATHOMIX is a trademark filed by Breathomix Intellectual Property B.V. on November 6, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Breathomix Intellectual Property B.V. (2 trademarks)

Bargelaan 200

Entity Type: 99

Breathomix B.V. (2 trademarks)

Bargelaan 200

Entity Type: 99

Trademark Details

Filing Date

November 6, 2020

Registration Date

April 5, 2022

Published for Opposition

January 18, 2022

Goods & Services

Computer hardware and peripheral devices; downloadable computer software, downloadable computer programs and downloadable mobile applications for analyzing volatile organic compounds in order to assist in making medical diagnosis, treatment selection or screening; downloadable computer application software and downloadable mobile applications for measuring and analyzing the mixture of volatile organic compounds in exhaled breath or body odor; downloadable computer software and downloadable mobile applications for use in operating and interpreting the results from medical apparatus and instruments; clinical software, namely, downloadable software and downloadable mobile applications for analyzing volatile organic compounds in order to assist in making medical diagnosis, treatment selection or screening; database systems for patient medical information comprised of computers and data processors; medical diagnostic software, namely, downloadable software and downloadable mobile applications as a medical device for diagnosing cancer, inflammatory and infectious diseases, and other diseases that leave traces in exhaled breath either directly or indirectly from the blood stream to the gas exchange in the lungs; computer systems comprised of computers and data processors; data processing equipment, namely, computers; electronic devices for measurements, recording, transmitting and reproducing information, data or images, namely, electric sensors and electronic sensing systems comprised of electronic sensors for detecting, analyzing and digitizing volatile organic compounds data; diagnostic apparatus for analyzing volatile organic compounds, not for medical purposes; testing apparatus, namely, apparatus for analyzing volatile organic compounds, not for medical purposes; chemical detection systems and apparatus comprised of electronic sensors for detecting, analyzing and digitizing volatile organic compounds data, computers and downloadable computer software for analyzing volatile organic compounds; sensors, namely, electronic sensors for detecting, analyzing and digitizing volatile organic compounds data; downloadable computer software, downloadable computer programs and downloadable mobile applications for analyzing volatile organic compounds for medical purposes; parts and fittings for all of the aforesaid goods

Medical services; consulting services relating to health care; healthcare services; health advice and information services, namely, advisory services relating to health and providing health information; medical care services; medical clinic services; health clinic services; medical health assessment services; medical health screening services; diagnostic health screening services in the field of volatile organic compounds; medical information services, namely, providing medical information to patients and medical professionals in the form of reports relating to health matters and diagnoses of diseases on the basis of volatile organic compounds research results; medical testing for diagnostic or treatment purposes; diagnostic testing, namely, medical testing for diagnostic or treatment purposes; testing for medical purposes, namely, medical testing for diagnostic or treatment purposes; advice, information and consultancy services relating to any of the aforesaid services

Scientific laboratory services; research services, namely, scientific research; design and development of computer and mobile computer hardware and software; design and development of computer and mobile computer hardware and software for medical and clinical use; medical research services; clinical research in the field of volatile organic compounds analysis; chemical analysis; chemical research; analytical laboratory services, namely, scientific laboratory services; biological research and analysis; laboratory analysis in the field of volatile organic compounds; laboratory services, namely, scientific laboratory services; laboratory testing services, namely, analyzing of volatile organic compounds; medical research laboratory services; computer programming; design and development of medical technology in the nature of computer and mobile computer hardware and software and medical apparatus; product research and development services relating to medical apparatus and instruments; advice, information and consultancy relating to any of the aforesaid services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 17, 2022 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Aug 24, 2022 XXSS
GENERIC MADRID TRANSACTION CREATED
Aug 24, 2022 XXCR
CHANGE OF OWNER RECEIVED FROM IB
Jul 9, 2022 CHLD
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 5, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Apr 5, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 18, 2022 NPUB
PUBLISHED FOR OPPOSITION
Jan 18, 2022 PUBO
NOTIFICATION PROCESSED BY IB
Jan 15, 2022 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 29, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 29, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 29, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 13, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Dec 13, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 13, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Dec 13, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Dec 13, 2021 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 8, 2021 GNFN
FINAL REFUSAL E-MAILED
Oct 8, 2021 GNFR
FINAL REFUSAL WRITTEN
Oct 8, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 9, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 9, 2021 TROA
REFUSAL PROCESSED BY IB
May 17, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 23, 2021 RFCS
REFUSAL PROCESSED BY MPU
Apr 23, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 22, 2021 RFCR
NON-FINAL ACTION WRITTEN
Apr 21, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 14, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 12, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 8, 2021 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 4, 2021 REPR